Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Mars Petcare acquires OptiGen, LLC
The acquisition includes an extensive biobank of more than 150,000 samples collected over two decades.

Acquisition includes licenses to a portfolio of genetic disease tests

Mars Petcare has taken possession of OptiGen LLC, A DNA diagnostics company specialising in canine inherited eye disorders.

The acquisition includes exclusive licenses to a portfolio of genetic disease tests patented in the U.S, Australia and a number of European countries. It also includes an extensive biobank of more than 150,000 samples collected over two decades, representing various canine eye diseases.

Mars Petcare said they will use the samples to find new genetic health markers for dogs.  
"Through our pioneering Wisdom Health business, Mars Petcare is leading the discovery of new genetic markers for pet health. As our scientists seek to improve the understanding of the genetic basis of pet health and disease, this acquisition will contribute to the development of personalized veterinary care," said Leonid Sudakov, president of Connected Solutions at Mars Petcare.

"We see our continued efforts to contribute to the ground-breaking companion animal genetics science as a great way to deliver on our purpose: 'A Better World for Pets'."

Cynthia Cole, general manager of Wisdom Health at Mars Petcare added: "We're at a pivotal time in companion animal genetic research, and with this acquisition, we will add to the growing body of knowledge to help veterinarians' ability to predict and treat inherited eye disorders for dogs."

"This acquisition is a welcome and natural evolution of OptiGen's 20-year history of working with conscientious dog owners, breeders, clubs and canine health registries around the world," said Sue Pearce-Kelling, OptiGen's President.

"OptiGen's and Wisdom Health's shared commitment to providing the highest quality of DNA testing for dogs while also supporting research aimed at identifying new genetic markers for inherited diseases, as well as our mutual respect for intellectual property where it exists in the field, makes this an excellent fit."

Mars Petcare acquired OptiGen on 10 April 218 and the companies will manage the transition over the course of 2018. 

Image (C) Mars Petcare

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'